These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38544680)

  • 1. Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.
    Fernando N; Tadic T; Li W; Patel T; Padayachee J; Santiago AT; Dang J; Chung P; Gutierrez E; Coolens C; Taylor E; Winter JD
    Phys Imaging Radiat Oncol; 2024 Apr; 30():100570. PubMed ID: 38544680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
    Fedorov A; Vangel MG; Tempany CM; Fennessy FM
    Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
    Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
    Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients.
    Lawrence LSP; Chan RW; Chen H; Keller B; Stewart J; Ruschin M; Chugh B; Campbell M; Theriault A; Stanisz GJ; MacKenzie S; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Czarnota GJ; Sahgal A; Lau AZ
    Radiother Oncol; 2021 Nov; 164():155-162. PubMed ID: 34592363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.
    Rabe M; Dietrich O; Forbrig R; Niyazi M; Belka C; Corradini S; Landry G; Kurz C
    Radiat Oncol; 2024 Mar; 19(1):31. PubMed ID: 38448888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
    Habrich J; Boeke S; Nachbar M; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
    Radiother Oncol; 2022 Sep; 174():141-148. PubMed ID: 35902042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
    Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
    Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
    Zhang KS; Neelsen CJO; Wennmann M; Glemser PA; Hielscher T; Weru V; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Eur J Radiol; 2023 Aug; 165():110898. PubMed ID: 37331287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration.
    Brighi C; Verburg N; Koh ES; Walker A; Chen C; Pillay S; de Witt Hamer PC; Aly F; Holloway LC; Keall PJ; Waddington DEJ
    Phys Imaging Radiat Oncol; 2022 Jul; 23():8-15. PubMed ID: 35734265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
    McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD
    Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.
    Sadinski M; Medved M; Karademir I; Wang S; Peng Y; Jiang Y; Sammet S; Karczmar G; Oto A
    Abdom Imaging; 2015 Oct; 40(7):2523-8. PubMed ID: 25805558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for improved reproducibility of ADC derivation on behalf of the Elekta MRI-linac consortium image analysis working group.
    Bisgaard ALH; Keesman R; van Lier ALHMW; Coolens C; van Houdt PJ; Tree A; Wetscherek A; Romesser PB; Tyagi N; Lo Russo M; Habrich J; Vesprini D; Lau AZ; Mook S; Chung P; Kerkmeijer LGW; Gouw ZAR; Lorenzen EL; van der Heide UA; Schytte T; Brink C; Mahmood F
    Radiother Oncol; 2023 Sep; 186():109803. PubMed ID: 37437609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeatability and reproducibility of MRI apparent diffusion coefficient applied on four different regions of interest for patients with axial spondyloarthritis and healthy volunteers scanned twice within a week.
    Møller JM; Østergaard M; Thomsen HS; Hangaard S; Sørensen IJ; Madsen OR; Pedersen SJ
    BJR Open; 2020; 2(1):20200004. PubMed ID: 33409446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
    Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
    Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
    Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
    Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
    Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
    Boss MA; Snyder BS; Kim E; Flamini D; Englander S; Sundaram KM; Gumpeni N; Palmer SL; Choi H; Froemming AT; Persigehl T; Davenport MS; Malyarenko D; Chenevert TL; Rosen MA
    J Magn Reson Imaging; 2022 Sep; 56(3):668-679. PubMed ID: 35143059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.